MedPath

Diagnosis of pubertal disorders

Not Applicable
Conditions
Health Condition 1: E309- Disorder of puberty, unspecified
Registration Number
CTRI/2019/10/021570
Lead Sponsor
Dr Rama Walia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Precocious Puberty,premature adrenarche,premature thelarche,anterior pituitary hormone deficiency,Delayed puberty,Children with normal puberty(controls)

Exclusion Criteria

Hypogonadotropic Hypogonadism on treatment with hCG and HMG.

Hypergonadotrpic Hypogonadism

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FSH stimulated Inhibin B as marker of onset of puberty. <br/ ><br>Timepoint: 12 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Basal Inhibin B, AMH and Inhibin B/AMH ratio as a marker of entry into puberty.Timepoint: 12 months;Effect of GnRH analogue stimulation on Inhibin B.Timepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath